Auckland City Hospital, Auckland, New Zealand.
Eur Heart J Acute Cardiovasc Care. 2013 Dec;2(4):323-33. doi: 10.1177/2048872613496941. Epub 2013 Aug 5.
Criteria for diagnosing myocardial infarction (MI) after coronary artery bypass grafting (CABG) are controversial. Uncertainties remain around the optimal threshold for biomarker elevation and the need for associated criteria. There are no studies of high-sensitivity troponin (hs-TnT) after CABG. We assessed whether using hs-TnT to define MI after CABG was associated with 30-day and medium-term mortality and evaluated the utility of adding to the troponin criteria new Q-waves or imaging evidence of new wall motion abnormality as suggested in the Universal Definition of MI.
Isolated CABG was performed in 818 patients from July 2010 to June 2012 and hs-TnT was measured 12-24 hours after CABG. Patients with rising baseline or missing troponins (n=258) were excluded. Thresholds of 140 ng/l (10-times 99th percentile upper reference limit) and 500 ng/l (10-times coefficient of variation of 10% for fourth-generation troponin T applied to hs-TnT) were prespecified.
Mean follow up was 1.8±0.6 years. On multivariate analyses, isolated hs-TnT rise >140 ng/l (n=360) or >500 ng/l (n=162) were not associated with mortality. Additional ECG and/or echocardiographic criteria plus hs-TnT >140 ng/l was associated with 30-day mortality (hazard ratio, HR, 4.92, 95% CI 1.34-18.1; p=0.017) and medium-term mortality (HR 3.44, 95% CI 1.13-10.5; p=0.030), whereas ECG and/or echocardiographic abnormalities with hs-TnT >500 ng/l was not (p=0.281 and p=0.123 for 30-day and medium-term mortality, respectively).
A definition for MI following CABG using hs-TnT with a cut point of 10-times 99th percentile upper reference limit and ECG and/or echocardiographic criteria predicts 30-day and medium-term mortality. These findings validate the Third Universal Definition of type 5 MI.
冠状动脉旁路移植术(CABG)后心肌梗死(MI)的诊断标准存在争议。生物标志物升高的最佳阈值以及相关标准的必要性仍存在不确定性。目前尚无关于 CABG 后高敏肌钙蛋白(hs-TnT)的研究。我们评估了使用 hs-TnT 定义 CABG 后 MI 是否与 30 天和中期死亡率相关,并评估了添加新的 Q 波或影像学证据作为 MI 的新壁运动异常的肌钙蛋白标准的效用,如通用 MI 定义中所建议的。
2010 年 7 月至 2012 年 6 月,对 818 例患者进行了单纯 CABG,并在 CABG 后 12-24 小时测量 hs-TnT。排除了基线升高或肌钙蛋白缺失的患者(n=258)。预设了 140ng/L(10 倍第 99 百分位上参考限)和 500ng/L(第四代肌钙蛋白 T 应用于 hs-TnT 的 10%变异系数的 10 倍)的阈值。
平均随访 1.8±0.6 年。多变量分析显示,孤立性 hs-TnT 升高>140ng/L(n=360)或>500ng/L(n=162)与死亡率无关。心电图和/或超声心动图标准加 hs-TnT>140ng/L 与 30 天死亡率(危险比,HR,4.92,95%CI 1.34-18.1;p=0.017)和中期死亡率(HR 3.44,95%CI 1.13-10.5;p=0.030)相关,而心电图和/或超声心动图异常伴 hs-TnT>500ng/L 则无相关性(30 天和中期死亡率分别为 p=0.281 和 p=0.123)。
使用 hs-TnT 切点为第 99 百分位上参考限的 10 倍和心电图和/或超声心动图标准的 CABG 后 MI 定义预测 30 天和中期死亡率。这些发现验证了 5 型 MI 的第三次通用定义。